Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Frontiers in Genetics|September 1, 2012
Posttranscriptional regulation of gene expression-adding another layer of complexity to the DNA damage responseJorge Boucas, Arina Riabinska, Mladen Jokic, et al.
Haematologica|June 25, 2026
Academic point-of-care anti-CD19 CAR T-cell therapy induces durable remission and transient paroxysmal nocturnal hemoglobinuria-type cell expansion in a patient with multi-refractory immune thrombocytopeniaKai Arne Plümer, Keven Hörster, Marcel Teichert, et al.
Frontiers in Immunology|October 11, 2021
Low Soluble Programmed Cell Death Protein 1 Levels After Allogeneic Stem Cell Transplantation Predict Moderate or Severe Chronic GvHD and Inferior Overall SurvivalLambros Kordelas, Ulrike Buttkereit, Falko M Heinemann, et al.
European Heart Journal Open|January 29, 2026
Sex-specific differences in cardiac transthyretin amyloidosis: addressing the diagnostic gap in womenJulia Vogel, Sophia Jura, Stephan Settelmeier, et al.
Scientific Reports|November 12, 2021
Targeting CD38 in acute myeloid leukemia interferes with leukemia trafficking and induces phagocytosisMeike Farber, Yiyang Chen, Lucas Arnold, et al.
Genes & Development|July 18, 2009
The combined status of ATM and p53 link tumor development with therapeutic responseHai Jiang, H Christian Reinhardt, Jirina Bartkova, et al.
Cell Reports|November 19, 2013
A reversible gene-targeting strategy identifies synthetic lethal interactions between MK2 and p53 in the DNA damage response in vivoSandra Morandell, H Christian Reinhardt, Ian G Cannell, et al.
Plos One|May 21, 2015
Label-Free Protein-RNA Interactome Analysis Identifies Khsrp Signaling Downstream of the p38/Mk2 Kinase Complex as a Critical Modulator of Cell Cycle ProgressionJorge Boucas, Christian Fritz, Anna Schmitt, et al.
Transplantation and Cellular Therapy|October 13, 2025
Treosulfan-Based Conditioning Ameliorates the Impact of Pretransplantation Measurable Residual Disease-Positivity in Acute Myeloid Leukemia Patients Allografted in RemissionJacob Pyka, Judith Metzdorf, Christian Reicherts, et al.
Cancer Discovery|February 22, 2014
A functional cancer genomics screen identifies a druggable synthetic lethal interaction between MSH3 and PRKDCFelix Dietlein, Lisa Thelen, Mladen Jokic, et al.
Pageof 9